 |
Prospector
Profile
3-6-002
|
| |
| Advanced Proteome Therapeutics Corporation |
NAICS |
541710 |
| BioSquare, 650 Albany Street, Suite 113,
Boston, MA 02118 |
Description |
Biotechnology |
| (604) 630-0770 |
Employees |
|
| |
Revenue |
(mil) |
0.0600 |
| |
Income |
(mil) |
-1.9000 |
| |
Assets |
(mil) |
1.6200 |
| |
Liability |
(mil) |
0.5400 |
| |
(for the year ended 2007-07-31) |
| |
|
Category:
Loss/Deficit
|
| |
|
Event:
Advanced Proteome Therapeutics Corporation posted a net loss of $1,895,980 on revenues of $58,933 for the year ended July 31, 2007, much higher than the $137,454 net loss on revenues of $10,531 in the prior year. The Company's balance sheet at July 31, 2007, showed $1,616,400 in total assets, $174,205 in total liabilities, $538,202 in non-controlling interest and $903,993 in total stockholders' equity.
|
| |
|
Intellectual Property:
The Company's major patent application covering several aspects of the technology has been submitted to the U.S. Patent and Trademark Office. Eight separate inventions including the modification of a target group, the preparation of activated polymer complexes, the modification of a biological molecule, and the modulatory mapping of biological molecules are disclosed and are under review. Additional intellectual property has been disclosed related to improvements in methodology, oral bioavailability and increased duration of action, and is being reviewed by patent counsel before filing. The Company's patent applications are Patent Application No. WO2004066917 and Patent Application No. US2004176575. [SEC Filing 20-F 02-15-08]
|
| |
|
Description:
Advanced Proteome Therapeutics Corporation, specializes in the redevelopment of protein therapeutics in the United States.
|
| |
|
Officers:
Alexander Krantz, Ph.D. (CEO, CFO & Dir.); Robert Bender (Dir.); Jean Bellin (Dir.); Russell E. Phares, Ph.D. (Dir.); Gary Hayes, M.D. (Dir.)
|
| |
|
Auditor:
BDO Dunwoody LLP
|
| |
|
Securities:
Common Stock Symbol APTCF.PK; Other OTC; 56,167,714 common shares oustanding
|
| |
| |
| |
| return to main page |
|
|
